AstraZeneca Takes Drug-Pricing Law Challenge To 4th Circ.
By Hailey Konnath · October 6, 2026, 11:02 PM EDT
AstraZeneca on Monday asked the Fourth Circuit to resurrect its suit challenging how the Centers for Medicare & Medicaid Services determines which drugs are subject to the landmark drug-pricing program, arguing...
To view the full article, register now.